Feature | June 10, 2007 | Cristen C. Bolan

A Fair Playing Field in Digital Mammography?

In a recent letter to the editor, an ITN reader brought up the decision made on May 23rd, 2006, to re-classify digital mammography from a Class III product to Class II. According to the reader, “This was widely thought to mean that the complicated and lengthy process of filing a PMA to gain FDA approval to market digital mammography would no longer be required.”
It was thought that the benefits of the proposed re-classification would enable a much simpler 510(k) application to FDA to be used to gain clearance to market digital mammography. In the meeting, Robert Jennings, M.D., of the FDA said: “The big difference which we feel goes a long way towards our goal of least burdensome approach to device clearance is that we will use, instead of a large clinical trial, simply reader evaluation of clinical films as is done in the ACR accreditation process.”
This would allow manufacturers entering the market to avoid the lengthy clinical study required in the PMA process. The new approach would also benefit patient care by not double exposing participants.
Although it was unanimously recommended that the FDA should develop the guidance documents required to reclassify digital mammography to a 510(k), nine months later, the FDA stated that it would take at least an additional one and a half to two years for the FDA to complete the guidance documents describing the requirements for a digital mammography 510(k). They added that the ultimate requirements would include a large clinical trial similar to that required for a PMA, including double exposure of participating patients and a one-year follow-up of negative diagnoses.
Why did the reader bring this to my attention? In hopes that other industry experts would join in on requesting that the FDA complete “the guidance documents for digital mammography 510(k) within the next six months” and “eliminate the need for a large clinical trial for a digital mammography 510(k).” This way, our reader believes, other qualified manufacturers would not be left sitting on the sidelines, while just a few players “divide up the large and growing digital mammography market.”
It begs the question – has the FDA established a fair playing field for all qualified manufacturers or does the market cater to a few powerhouses to lead the medical imaging market? That’s for you to decide. I just hope, above all, it’s catering to the patients.

We welcome your comments on the topics found in Imaging Technology News.
Please send your thoughts to [email protected]
Please send press releases to [email protected]
and chart responses to [email protected]

Related Content

Sponsored Content | Videos | Breast Imaging | July 28, 2017
Nancy Cappello, Ph.D., executive director and founder of Are You Dense Inc. and Are You Dense Advocacy, explains how
Volpara Solutions to Showcase Volpara Enterprise DDP Software at AHRA 2017
News | Mammography | July 11, 2017
Volpara Solutions Inc. will showcase its new Volpara Enterprise DDP software at the Association for Medical Imaging...
Fujifilm Showcases Digital Radiography, Mammography Innovations at AHRA 2017
News | Digital Radiography (DR) | July 06, 2017
Fujifilm Medical Systems U.S.A. Inc. will present its comprehensive portfolio of digital radiography (DR) and...
Solis Mammography Ranks No. 19 in Dallas Business Journal’s Middle Market 50
News | Mammography | June 30, 2017
June 30, 2017 — Solis Mammography was named the 19th fastest-growing, middle-market company in North Texas by the
GE Healthcare Announces First U.S. Installation of Senographe Pristina Mammography System
News | Mammography | June 29, 2017
GE Healthcare has collaborated with Boca Raton Regional Hospital (Boca Raton, Fla.) to bring a more comfortable...
New Study Highlights Breakthrough Therapy to Reduce Mammographic Breast Density
News | Breast Density | June 28, 2017
Stephen N. Birrell, M.D., Ph.D., presented breakthrough findings into the reduction of mammographic breast density at...
Therapixel Wins the Digital Mammography Challenge
News | Mammography | June 23, 2017
June 23, 2017 — French radiology technology company Therapixel was recently named the winner of the Digital Mammograp
MRI Plus Mammography Improves Detection of New Breast Cancer After Surgery
News | Breast Imaging | June 22, 2017
A new article published by JAMA Oncology compares outcomes for combined mammography and magnetic resonance imaging (MRI...
mammogram

Photo courtesy of Barco

News | Mammography | June 08, 2017
An analysis of breast cancer data revealed that many small breast cancers have an excellent prognosis because they are...
News | Mammography | June 07, 2017
Hologic, Inc. announced that the Genius 3D Mammography exam is now the only mammogram that is FDA-approved as superior...
Overlay Init